Broadleaf Partners, LLC Biogen Inc. Transaction History

Broadleaf Partners, LLC

$401 Million
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$282.99 - $369.05 $7.02 Million - $9.16 Million	-24,812 Closed	0 $0
Q2 2021 Jul 15, 2021	SELL	$259.0 - $414.71 $182,854 - $292,785	-706 Reduced 2.77%	24,812 $8.59 Million
Q1 2021 Apr 23, 2021	BUY	$242.95 - $284.63 $230,073 - $269,544	947 Added 3.85%	25,518 $7.14 Million
Q4 2020 Feb 24, 2021	BUY	$236.26 - $355.63 $9,450 - $14,225	40 Added 0.16%	24,571 $6.02 Million
Q3 2020 Oct 23, 2020	BUY	$264.77 - $305.71 $976,471 - $1.13 Million	3,688 Added 17.69%	24,531 $6.96 Million
Q2 2020 Aug 04, 2020	BUY	$258.66 - $342.55 $49,921 - $66,112	193 Added 0.93%	20,843 $5.58 Million
Q1 2020 May 05, 2020	SELL	$268.85 - $341.04 $42,478 - $53,884	-158 Reduced 0.76%	20,650 $6.53 Million
Q4 2019 Jan 31, 2020	BUY	$220.06 - $304.07 $898,945 - $1.24 Million	4,085 Added 24.43%	20,808 $6.17 Million
Q3 2019 Oct 21, 2019	BUY	$217.44 - $243.88 $2.02 Million - $2.27 Million	9,307 Added 125.5%	16,723 $3.89 Million
Q1 2019 Apr 09, 2019	SELL	$216.71 - $338.96 $508,618 - $795,539	-2,347 Reduced 24.04%	7,416 $2.43 Million
Q4 2018 Jan 15, 2019	SELL	$278.5 - $352.75 $47,066 - $59,614	-169 Reduced 1.7%	9,763 $2.94 Million
Q3 2018 Oct 12, 2018	BUY	$293.51 - $383.83 $557,375 - $728,893	1,899 Added 23.64%	9,932 $3.51 Million
Q2 2018 Aug 07, 2018	SELL	$257.52 - $306.91 $2.07 Million - $2.47 Million	-8,033 Reduced 50.0%	8,033 $2.33 Million
Q2 2018 Jul 17, 2018	BUY	$257.52 - $306.91 $566,544 - $675,202	2,200 Added 15.87%	16,066 $4.66 Million
Q1 2018 Apr 20, 2018	BUY	$260.13 - $367.91 $1.54 Million - $2.17 Million	5,902 Added 74.11%	13,866 $3.8 Million
Q4 2017 Jan 12, 2018	BUY	$307.64 - $344.58 $2.45 Million - $2.74 Million	7,964	7,964 $2.54 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$3.3 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$3.25 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.89 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.41 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$1.13 Billion
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Broadleaf Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Broadleaf Partners, LLC with notifications on news.

Account